Nakeetsha Dryer
Psychiatric/Mental Health · Fort Payne, ALNPI 1518217876
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 409 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in AL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 409 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
- AbbVie$1K
- Neurocrine Biosciences, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$784
- Johnson & Johnson$774
- Alkermes, Inc.$669
- plus $3K from 24 others
What the payments were for
- Food & beverage$9,028100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 67 | $1,534 |
| AbbVie | 64 | $1,335 |
| Neurocrine Biosciences, Inc. | 45 | $1,130 |
| Otsuka America Pharmaceutical, Inc. | 44 | $784 |
| Johnson & Johnson | 20 | $774 |
| Alkermes, Inc. | 26 | $669 |
| Axsome Therapeutics, Inc. | 35 | $603 |
| Lundbeck LLC | 14 | $305 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $231 |
| Vanda Pharmaceuticals Inc. | 9 | $218 |
| Corium, LLC | 10 | $214 |
| Tris Pharma Inc | 6 | $178 |
| Braeburn Inc. | 9 | $170 |
| Indivior Inc. | 5 | $120 |
| Eisai Inc. | 8 | $114 |
| Neos Therapeutics, LP | 5 | $90 |
| Almatica Pharma LLC | 4 | $84 |
| Sunovion Pharmaceuticals Inc. | 5 | $80 |
| Bausch Health US, LLC | 4 | $66 |
| E.r. Squibb & Sons, L.L.C. | 1 | $45 |
| Ironshore Pharmaceuticals Inc. | 2 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $41 |
| Supernus Pharmaceuticals, Inc. | 2 | $36 |
| Adlon Therapeutics L.p. | 3 | $35 |
| Idorsia Pharmaceuticals US Inc | 2 | $34 |
| Pear Therapeutics (US), Inc. | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $21 |
| Merck | 1 | $17 |
| Orexo US, Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$445
- INVEGA SUSTENNA$246
- SPRAVATO$166
- INVEGA TRINZA$138
- INGREZZA$122
- VRAYLAR$118
- Azstarys$110
How this compares
$9,028 in reported general payments places this provider in the 90th percentile of 378 psychiatric/mental health providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 54 | $11,463 |
| Buprenorphine Hcl | 13 | $1,690 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Fort Payne
- Laura GrahamMontgomery$80K
- Yuliya SpencerBirmingham$65K
- Keri BarrBay Minette$35K
- John HayesMobile$30K
- Logan ThrasherHoover$22K
- Anthony PhillipsHelena$15K
- Ian KinzerHuntsville$15K
- Latisha AliHoover$15K
- Taylor BarrettGadsden$15K
- Angela GarrardGadsden$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.